Literature DB >> 19238022

Subcutaneous fat necrosis as the presenting feature of a pancreatic carcinoma: the challenge of differentiating endocrine and acinar pancreatic neoplasms.

Sean K Martin1, Gaurava Agarwal, Garrett R Lynch.   

Abstract

The association between pancreatic panniculitis and pancreatic disease is well described, but differentiation among the neoplastic causes of the syndrome remains difficult due to substantial overlap in histological and immunohistochemical features. We report a case of subcutaneous fat necrosis as the presenting feature in a 61-year-old man with metastatic carcinoma of pancreatic origin. Previous pathological evaluation of the patient's liver biopsy led to an initial diagnosis of adenocarcinoma of unknown primary site. One month later, the patient presented with pancreatic panniculitis, prompting further investigation. Immunohistochemistry was consistent with neuroendocrine differentiation, but the patient rapidly decompensated and died before the evaluation was complete, leaving the definitive diagnosis in question. In our review of the published reports of tumor types associated with pancreatic panniculitis, we found that immunohistochemical staining and electron microscopy can and should be used in conjunction with clinical correlation to accurately differentiate neuroendocrine tumors from carcinomas with acinar cell features. Accurate diagnosis of these tumors is necessary to determine prognosis and define appropriate therapy.

Entities:  

Mesh:

Year:  2009        PMID: 19238022     DOI: 10.1097/MPA.0b013e31817dd07e

Source DB:  PubMed          Journal:  Pancreas        ISSN: 0885-3177            Impact factor:   3.327


  5 in total

1.  An effective personalized approach to a rare tumor: prolonged survival in metastatic pancreatic acinar cell carcinoma based on genetic analysis and cell line development.

Authors:  Matthew D Armstrong; Daniel Von Hoff; Bruce Barber; Laura A Marlow; Christina von Roemeling; Simon J Cooper; Patrick Travis; Elizabeth Campbell; Ricardo Paz-Fumagalli; John A Copland; Gerardo Colon-Otero
Journal:  J Cancer       Date:  2011-03-08       Impact factor: 4.207

2.  Novel patient-derived xenograft mouse model for pancreatic acinar cell carcinoma demonstrates single agent activity of oxaliplatin.

Authors:  Jason C Hall; Laura A Marlow; Adam C Mathias; Louis K Dawson; William F Durham; Kenneth A Meshaw; Robert J Mullin; Aidan J Synnott; Daniel L Small; Murli Krishna; Daniel von Hoff; Julia Schüler; Steven N Hart; Fergus J Couch; Gerardo Colon-Otero; John A Copland
Journal:  J Transl Med       Date:  2016-05-10       Impact factor: 5.531

Review 3.  Pancreatic panniculitis in a patient with pancreatic-type acinar cell carcinoma of the liver--case report and review of literature.

Authors:  Sebastian Zundler; Ramona Erber; Abbas Agaimy; Arndt Hartmann; Franklin Kiesewetter; Deike Strobel; Markus F Neurath; Dane Wildner
Journal:  BMC Cancer       Date:  2016-02-20       Impact factor: 4.430

4.  Acinic cell carcinoma with extensive neuroendocrine differentiation: a diagnostic challenge.

Authors:  Somak Roy; Kajal Kiran Dhingra; Parul Gupta; Nita Khurana; Bulbul Gupta; Ravi Meher
Journal:  Head Neck Pathol       Date:  2009-03-26

5.  Prolonged Survival in a Patient with a Pancreatic Acinar Cell Carcinoma.

Authors:  Anne Ploquin; Capucine Baldini; Perrine Vuagnat; Samira Makhloufi; Christophe Desauw; Mohamed Hebbar
Journal:  Case Rep Oncol       Date:  2015-10-22
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.